Putnam Biorevolution ETFSYNBETF
13F holders, Q2 2025 (June 30)4holders
0new positions
0sold out
$28.33avg. 13F price*
At the end of Q2 2025, 4 institutions reported holding Putnam Biorevolution ETF (SYNB) in their 13F filings, unchanged from Q1 2025. 0 opened new positions and 0 sold out. The largest holders were Franklin Resources Inc. ($3.5M), Royal Bank of Canada ($43K) and UBS Group AG ($368).
- Company
- Putnam Biorevolution ETF
- CUSIP
- 746729805
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 592 shares sold, net −592 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Franklin Resources Inc. | 0.00% | No change | 125,000 | $3.5M |
| Royal Bank of Canada | 0.00% | Reduce -28.1% | 1,516 | $43K |
| UBS Group AG | 0.00% | No change | 13 | $368 |
| Osaic Holdings, Inc. | 0.00% | No change | 2 | $56 |
"% of holder's portfolio" is SYNB's weight in each manager's 13F, not the share of Putnam Biorevolution ETF the manager owns.